SunTrust Banks, Inc. Reiterates Hold Rating for Quintiles Transitional Holdings Inc. (Q)
Quintiles Transitional Holdings Inc. (NYSE:Q)‘s stock had its “hold” rating restated by stock analysts at SunTrust Banks, Inc. in a research report issued on Friday. They presently have a $114.00 price target on the medical research company’s stock. SunTrust Banks, Inc.’s price objective indicates a potential upside of 5.54% from the company’s current price. SunTrust Banks also issued estimates for Quintiles Transitional Holdings’ FY2017 earnings at $4.60 EPS, FY2018 earnings at $5.48 EPS and FY2019 earnings at $6.48 EPS.
A number of other equities research analysts have also recently weighed in on Q. Robert W. Baird upgraded shares of Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $76.00 to $93.00 in a research note on Friday, July 7th. Zacks Investment Research upgraded shares of Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research note on Thursday, July 27th. Barclays PLC restated an “overweight” rating and set a $98.00 price objective (up from $90.00) on shares of Quintiles Transitional Holdings in a research note on Monday, July 17th. Royal Bank Of Canada began coverage on shares of Quintiles Transitional Holdings in a research note on Tuesday, September 19th. They set an “outperform” rating and a $116.00 price objective on the stock. Finally, Argus lifted their price objective on shares of Quintiles Transitional Holdings from $98.00 to $104.00 and gave the company a “buy” rating in a research note on Monday, September 18th. Ten research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Quintiles Transitional Holdings presently has a consensus rating of “Buy” and an average target price of $102.33.
Shares of Quintiles Transitional Holdings (NYSE:Q) opened at $108.02 on Friday. The company has a market cap of $22.67 billion, a PE ratio of 24.50, a price-to-earnings-growth ratio of 1.78 and a beta of 0.65. The company has a quick ratio of 1.23, a current ratio of 1.22 and a debt-to-equity ratio of 1.29.
Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.05. The company had revenue of $2.02 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Quintiles Transitional Holdings had a return on equity of 12.60% and a net margin of 0.58%. The firm’s quarterly revenue was up 77.6% compared to the same quarter last year. During the same period last year, the business posted $1.00 earnings per share. sell-side analysts expect that Quintiles Transitional Holdings will post 4.62 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/11/04/suntrust-banks-inc-reiterates-hold-rating-for-quintiles-transitional-holdings-inc-q.html.
In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 5,218,245 shares of Quintiles Transitional Holdings stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $97.33, for a total transaction of $507,891,785.85. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Ari Bousbib sold 92,160 shares of Quintiles Transitional Holdings stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $90.35, for a total value of $8,326,656.00. Following the transaction, the insider now directly owns 1,082,919 shares in the company, valued at approximately $97,841,731.65. The disclosure for this sale can be found here. Insiders sold a total of 14,254,462 shares of company stock worth $1,367,822,566 in the last three months. 6.40% of the stock is currently owned by company insiders.
A number of large investors have recently added to or reduced their stakes in Q. Prudential Financial Inc. grew its stake in Quintiles Transitional Holdings by 24.6% during the 1st quarter. Prudential Financial Inc. now owns 18,721 shares of the medical research company’s stock valued at $1,508,000 after acquiring an additional 3,700 shares in the last quarter. FMR LLC lifted its holdings in shares of Quintiles Transitional Holdings by 11.2% during the 1st quarter. FMR LLC now owns 215,936 shares of the medical research company’s stock valued at $17,389,000 after buying an additional 21,742 shares during the last quarter. Teachers Advisors LLC lifted its holdings in shares of Quintiles Transitional Holdings by 23.6% during the 1st quarter. Teachers Advisors LLC now owns 381,161 shares of the medical research company’s stock valued at $30,695,000 after buying an additional 72,728 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Quintiles Transitional Holdings by 43.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 609,628 shares of the medical research company’s stock valued at $49,089,000 after buying an additional 186,027 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in shares of Quintiles Transitional Holdings during the 1st quarter valued at about $4,957,000. 93.03% of the stock is currently owned by institutional investors.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.